Tao Zhang

Tao Zhang has a solid work experience in the finance field, with a focus on financial planning and analysis. Tao started their career at Delphi in 2013, where they held various roles as a financial analyst, including positions in global FP&A, business development, and strategy, M&A, and divestures. In 2017, they joined Eli Lilly and Company as a senior finance manager and later became an associate director of financial planning and analysis. In 2021, Tao joined Roche as a finance enterprise partner before moving on to LianBio, where they currently serve as the director of financial planning & analysis and senior director of finance.

Tao Zhang completed a Master of Business Administration (M.B.A.) degree at the Ivey Business School at Western University from 2016 to 2017. Prior to that, from 2011 to 2012, Tao pursued a Master's Degree in Finance at Case Western Reserve University. Tao also holds a Bachelor of Business Administration (B.B.A.) degree in Finance from Fudan University, which was completed between 2007 and 2011.